Cross Country Healthcare, Inc. Stock price

Equities

CCRN

US2274831047

Employment Services

Market Closed - Nasdaq 04:30:01 2024-03-18 pm EDT 5-day change 1st Jan Change
17.9 USD +4.50% Intraday chart for Cross Country Healthcare, Inc. -3.97% -20.94%
Sales 2024 * 1.48B Sales 2025 * 1.54B Capitalization 622M
Net income 2024 * 32M Net income 2025 * 43M EV / Sales 2024 * 0.38 x
Net cash position 2024 * 54.37M Net cash position 2025 * 109M EV / Sales 2025 * 0.33 x
P/E ratio 2024 *
18.9 x
P/E ratio 2025 *
14.5 x
Employees 13,131
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.16%
More Fundamentals * Assessed data
Dynamic Chart
Barrington Cuts Price Target on Cross Country Healthcare to $24 From $26, Keeps Outperform Rating MT
UBS Adjusts Cross Country Healthcare Price Target to $19 From $22, Maintains Neutral Rating MT
Truist Adjusts Cross Country Healthcare's Price Target to $16 From $22, Keeps Hold Rating MT
Transcript : Cross Country Healthcare, Inc., Q4 2023 Earnings Call, Feb 21, 2024
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 EPS $0.29, vs. Street Est of $0.27 MT
Earnings Flash (CCRN) CROSS COUNTRY HEALTHCARE Posts Q4 Revenue $414M, vs. Street Est of $404.5M MT
(CCRN) CROSS COUNTRY HEALTHCARE Expects Q1 EPS Range $0.15 - $0.25 MT
Cross Country Healthcare, Inc. Announces Daniel J. White Departs as Chief Commercial Officer, Effective March 31, 2024 CI
Tranche Update on Cross Country Healthcare, Inc.'s Equity Buyback Plan announced on August 16, 2022. CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cross Country Healthcare, Inc. Provides Earnings Guidance for the First Quarter of 2024 CI
Cross Country Healthcare, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
JMP Securities Initiates Cross Country Healthcare With Market Perform Rating MT
UBS Initiates Coverage on Cross Country Healthcare With Neutral Rating, $22 Price Target MT
Barrington Cuts Price Target on Cross Country Healthcare to $26 From $29, Keeps Outperform Rating MT
More news

Latest transcript on Cross Country Healthcare, Inc.

1 day+4.50%
1 week-3.97%
Current month-2.03%
1 month+1.99%
3 months-14.40%
6 months-24.95%
Current year-20.94%
More quotes
1 week
16.77
Extreme 16.77
18.42
1 month
15.81
Extreme 15.81
19.14
Current year
15.81
Extreme 15.81
23.64
1 year
15.65
Extreme 15.65
28.75
3 years
11.50
Extreme 11.5
40.12
5 years
4.50
Extreme 4.5
40.12
10 years
4.50
Extreme 4.5
40.12
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 21-01-24
Chief Executive Officer 63 85-12-31
Director of Finance/CFO 54 14-03-31
Members of the board TitleAgeSince
Director/Board Member 73 07-04-30
Director/Board Member 68 15-05-11
Chief Executive Officer 63 85-12-31
More insiders
Date Price Change Volume
24-03-18 17.9 +4.50% 506,652
24-03-15 17.13 +1.60% 2,081,177
24-03-14 16.86 -3.77% 310,403
24-03-13 17.52 -4.73% 345,444
24-03-12 18.39 -1.34% 202,375

Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT

More quotes
Cross Country Healthcare, Inc. is a technology-enabled workforce solution and advisory company. The Company operates through two segments: Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment provides workforce solutions and traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and allied professionals, temporary placement of healthcare leaders within nursing, allied, physician, human resources, and managed services programs (MSP) services, in-home care services, and outsourcing services. The Physician Staffing segment provides physicians in many specialties, as well as certified registered nurse anesthetists, nurse practitioners, and physician assistants as independent contractors on temporary assignments throughout the United States at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, and government facilities.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
17.9 USD
Average target price
19.5 USD
Spread / Average Target
+8.94%
Consensus
  1. Stock
  2. Equities
  3. Stock Cross Country Healthcare, Inc. - Nasdaq